Skip to contentV
Vsee Health, Inc.
V
VSEEWVsee Health, Inc. Q1 2026 · 10-Q
Revenue$3.16M$3.16M−4.9% vs Q1 2025 Net Income-$2.60M-$2.60MN/M vs Q1 2025 EPS Diluted-$0.05-$0.05N/M vs Q1 2025 Gross Profit$1,198,111−35.6% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Vsee Health, Inc. · CIK 1864531 · Engraved from SEC EDGAR
Operating Cash Flow-$2,452,191N/M Free Cash Flowderived-$2,478,943N/M Margins · derivedGross margin37.9%−18.1 pt vs Q1 2025
Operating margin-94.1%−39.0 pt vs Q1 2025
Net margin-82.3%+36.9 pt vs Q1 2025
ended Mar 31, 2026 · filed May 15, 2026 · 45 d after period end